Granules India’s net profit increased 39 per cent at ₹182 crore in the second quarter ended September 30, 2026 compared to ₹130 crore in the corresponding quarter of the previous financial year.
The total revenue of the Hyderabad-based company grew 20 per cent at ₹1,560 crore in the quarter under review, against ₹1,297 crore in the year-ago period.
“Our quarterly revenue crossed ₹1,500 crore in Q2 FY27 with EBITDA of ₹338 crore despite higher input and logistics costs from tensions in West Asia. Cost pressures will persist and we are working with customers to manage them with a lag,’’ Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India, said in a release on Monday.
“We recently concluded a US FDA audit at the Gagillapur site. The inspection progressed constructively and the observations are of a nature that we believe can be fully addressed through our responses and corrective and preventive actions, and we will continue to engage transparently with the agency,’’ he added.
Published on November 2, 2026
